Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies

References

• Altomare, G., Ayala, F., Berardesca, E., Chimenti, S., Giannetti, A., Girolomoni, G., Lotti, T., Martini, P., Peserico, A., Guerra, A.P., Vena, G.A. Etanercept provides a more physiological approach in the treatment of psoriasis. Dermatol Ther 2008, 21 Suppl 2, S1–14.
   PubMedGoogle Scholar
• Etanercept: Summary of Product Characteristics (24/08/2011 Enbrel -EMA/H/C/000262 -II/126).
   Google Scholar
• Barrera, M.V., Habicheyn, S., Mendiola, M.V., Herrera Ceballos, E. Etanercept in the treatment and retreatment of psoriasis in daily clinical practice. Eur J Dermatol 2008, 18, 683–687.
   PubMed Web of Science ®Google Scholar
• Daudén, E., Griffiths, C.E., Ortonne, J.P., Kragballe, K., Molta, C.T., Robertson, D., Pedersen, R., Estojak, J., Boggs, R. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study. J Eur Acad Dermatol Venereol 2009, 23, 1374–1382.
   PubMed Web of Science ®Google Scholar
• Ortonne, J.P., Taïeb, A., Ormerod, A.D., Robertson, D., Foehl, J., Pedersen, R., Molta, C., Freundlich, B. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept. Br J Dermatol 2009, 161, 1190–1195.
   PubMed Web of Science ®Google Scholar
• Segaert, S. Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update. J Inflamm Res 2009, 2, 29–36.
   PubMedGoogle Scholar
• Prodanovich, S., Ricotti, C., Glick, B.P., Inverardi, L., Leonardi, C.L., Kerdel, F. Etanercept: an evolving role in psoriasis and psoriatic arthritis. Am J Clin Dermatol 2010, 11 Suppl 1, 3–9.
   PubMed Web of Science ®Google Scholar
• Bachmann, F., Kokolakis, G., Sterry, W., Philipp, S. Etanercept: overview of clinical experience in the treatment of psoriasis and psoriatic arthritis. Int J Clin Rheumatol 2011, 6, 135–155.
   Google Scholar
• Papp, K.A., Krueger, G.G., Jemec, G.B.E., van de Kerkhof, P., Robertson, D., Estojak, J., Pedersen, R., Foehl, J., Wajdula, J., Boggs, R., Molta C. Long-term, continuous dosing of etanercept in patients with plaque psoriasis. Expert Rev Dermatol 2011, 6, 361–373.
   Google Scholar
• Costanzo, A., Mazzotta, A., Papoutsaki, M., Nisticò, S., Chimenti, S. Safety and efficacy study on etanercept in patients with plaque psoriasis. Br J Dermatol 2005, 152, 187–189.
   PubMed Web of Science ®Google Scholar
• Arcese, A., Aste, N., Bettacchi, A., Camplone, G., Cantoresi, F., Caproni, M., D’Amico, D., Fabbri, P., Filosa, G., Galluccio, A., Hansel, K., Lisi, P., Micali, G., Musumeci, M.L., Nicolini, M., Parodi, A., Patania, M., Pezza, M., Potenza, C., Richetta, A., Simonacci, M., Trevisan, P., Valenti, G., Calvieri, S. Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation. Clin Drug Investig 2010, 30, 507–516.
   PubMed Web of Science ®Google Scholar
• Esposito, M., Giunta, A., Mazzotta, A., Babino, G., Talamonti, M., Chimenti, M.S., Chimenti, S. Continuous treatment of plaque-type psoriasis with etanercept: an observational long-term experience. Int J Immunopathol Pharmacol 2010, 23, 479–485.
   Web of Science ®Google Scholar
• Mazzotta, A., Esposito, M., Costanzo, A., Chimenti, S. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Am J Clin Dermatol 2009, 10, 319–324.
   PubMed Web of Science ®Google Scholar
• Esposito, M., Mazzotta, A., Saraceno, R., Schipani, C., Chimenti, S. Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis. Int J Immunopathol Pharmacol 2009, 22, 219–225.
   PubMed Web of Science ®Google Scholar
• Campione, E., Mazzotta, A., Paternò, E.J., Diluvio, L., Prinz, J.C., Chimenti, S. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients. Acta Derm Venereol 2009, 89, 2888–2891.
   Web of Science ®Google Scholar
• Cassano, N., Loconsole, F., Galluccio, A., Miracapillo, A., Pezza, M., Vena, G.A. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study). Int J Immunopathol Pharmacol 2006, 19, 225–229.
   PubMed Web of Science ®Google Scholar
• Cassano, N., Loconsole, F., Miracapillo, A., Travaglini, M., Digiuseppe, M.D., Congedo, M., Galluccio, A., Buquicchio, R., Mastrandrea, V., Filieri, M., Raho, G., Pezza, M., Vena, G.A. Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Taranta Plastic Study Group. Int J Immunopathol Pharmacol 2010, 23, 797–802.
   PubMed Web of Science ®Google Scholar
• Warren, R.B., Brown, B.C., Lavery, D., Ashcroft, D.M., Griffiths, C.E. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol 2009, 160, 162–169.
   PubMed Web of Science ®Google Scholar
• Driessen, R.J., Boezeman, J.B., van de Kerkhof, P.C., de Jong, E.M. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. Br J Dermatol 2009, 160, 670–675.
   PubMed Web of Science ®Google Scholar
• Daly, M., Alikhan, A., Armstrong, A.W. Combination systemic therapies in psoriatic arthritis. J Dermatolog Treat 2011, 22, 276–284.
   PubMed Web of Science ®Google Scholar
• Gisondi, P., Del Giglio, M., Cotena, C., Girolomoni, G. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008, 158, 1345–1349.
   PubMed Web of Science ®Google Scholar
• Vena, G.A., Mastrandrea, V., Battaglini, S., Loconsole, F., Buquicchio, R., Cassano, N. Combination of etanercept and twice-weekly administration of cyclosporin in psoriasis unsatisfactorily controlled by etanercept monotherapy: a retrospective analysis. Eur J Inflamm 2012 (In Press).
   PubMed Web of Science ®Google Scholar
• De Simone, C., D’Agostino, M., Capizzi, R., Capponi, A., Venier, A., Caldarola, G. Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis. Eur J Dermatol 2011, 21, 568–572.
   PubMed Web of Science ®Google Scholar
• Paller, A.S., Siegfried, E.C., Langley, R.G., Gottlieb, A.B., Pariser, D., Landells, I., Hebert, A.A., Eichenfield, L.F., Patel, V., Creamer, K., Jahreis, A.; Etanercept Pediatric Psoriasis Study Group. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 2008, 358, 241–251.
   PubMed Web of Science ®Google Scholar
• Papoutsaki, M., Costanzo, A., Mazzotta, A., Gramiccia, T., Soda, R., Chimenti, S. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol 2006, 154, 181–183.
   PubMed Web of Science ®Google Scholar
• Esposito, M., Mazzotta, A., de Felice, C., Papoutsaki, M., Chimenti, S. Treatment of erythrodermic psoriasis with etanercept. Br J Dermatol 2006, 155, 156–159.
   PubMed Web of Science ®Google Scholar
• Esposito, M., Mazzotta, A., Casciello, C., Chimenti, S. Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series. Dermatology (Basel) 2008, 216, 355–360.
   PubMed Web of Science ®Google Scholar